Vanguard Group’s Onconetix ONCO Stock Holding History

Vanguard Group’s Portfolio ONCO Stock Details ONCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Hold	0	–	-$12.3K	–	4371
2024 Q2	–	Hold	0	–	–	–	4383
2024 Q1	–	Hold	0	–	–	–	4419
2023 Q4	–	Sell	-1	Closed	-$55.1K	–	4463
2023 Q3	$100K	Hold	1	–	–	﹤0.01%	4346
2023 Q2	$200K	Hold	1	–	–	﹤0.01%	4316
2023 Q1	$189K	Buy	+1	New	+$200K	﹤0.01%	4327
2022 Q4	–	Hold	0	–	–	–	4446
2022 Q3	–	Hold	0	–	–	–	4515

Other funds holding ONCO

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Vanguard Group's ONCO Position: Q3 2024 in Review

Vanguard Group held its Onconetix (ONCO) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4371.

Vanguard Group first reported a position in ONCO in Q1 2023 and has held it in 3 quarters since. The position peaked at $200K in Q2 2023. 5 funds tracked by Wall St. Rank hold ONCO as of Q3 2024.

Vanguard Group held 0 shares of Onconetix worth $0 as of Q3 2024.
Vanguard Group left its Onconetix share count unchanged in Q3 2024.
Onconetix made up ﹤0.01% of Vanguard Group's portfolio in Q3 2024, its #4371 holding.
Vanguard Group first reported a position in Onconetix in Q1 2023 and has held it in 3 quarters since.
Vanguard Group's Onconetix position peaked at $200K in Q2 2023.
5 funds tracked by Wall St. Rank held Onconetix as of Q3 2024.

Based on Vanguard Group's 13F filing for Q3 2024, filed 13 Nov 2024.